171 related articles for article (PubMed ID: 2571086)
1. Screening for multiple endocrine neoplasia type 2a with DNA-polymorphism analysis.
Sobol H; Narod SA; Nakamura Y; Boneu A; Calmettes C; Chadenas D; Charpentier G; Chatal JF; Delepine N; Delisle MJ
N Engl J Med; 1989 Oct; 321(15):996-1001. PubMed ID: 2571086
[TBL] [Abstract][Full Text] [Related]
2. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.
Lips CJ; Landsvater RM; Höppener JW; Geerdink RA; Blijham G; van Veen JM; van Gils AP; de Wit MJ; Zewald RA; Berends MJ
N Engl J Med; 1994 Sep; 331(13):828-35. PubMed ID: 7915822
[TBL] [Abstract][Full Text] [Related]
3. Screening for multiple endocrine neoplasia type 2A with DNA-polymorphism analysis.
Lamothe EM; Narod SA; Miller S; Goodfellow PJ; Cole DE; Gilchrist D; Pausova Z; Goltzman D; Hendy GN
Henry Ford Hosp Med J; 1992; 40(3-4):224-6. PubMed ID: 1362410
[TBL] [Abstract][Full Text] [Related]
4. Early detection of hereditary medullary thyroid cancer with polymorphic DNA probes. Groupe d'Etude des Tumeurs a Calcitonine.
Narod SA; Sobol H; Schuffenecker I; Ezekowitz RA; Lenoir GM
Henry Ford Hosp Med J; 1989; 37(3-4):106-8. PubMed ID: 2576937
[TBL] [Abstract][Full Text] [Related]
5. Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms.
Larsson C; Shepherd J; Nakamura Y; Blomberg C; Weber G; Werelius B; Hayward N; Teh B; Tokino T; Seizinger B
J Clin Invest; 1992 Apr; 89(4):1344-9. PubMed ID: 1348254
[TBL] [Abstract][Full Text] [Related]
6. Application of linked DNA markers to screening families with multiple endocrine neoplasia type 2A.
Telenius H; Mathew CG; Nakamura Y; Easton DF; Clark J; Neumann HP; Ziegler WH; Schinzel A; Ponder BA
Eur J Surg Oncol; 1990 Apr; 16(2):134-40. PubMed ID: 1969807
[TBL] [Abstract][Full Text] [Related]
7. [An application of genetic diagnosis in MEN2a].
Kojima K
Nihon Rinsho; 1994 Apr; 52(4):1087-92. PubMed ID: 7910862
[TBL] [Abstract][Full Text] [Related]
8. Practical guidelines for DNA-based testing in multiple endocrine neoplasia type 1.
Larsson C; Nordenskjold M; Skogseid B; Oberg K
Henry Ford Hosp Med J; 1992; 40(3-4):173-6. PubMed ID: 1362400
[TBL] [Abstract][Full Text] [Related]
9. Multiple endocrine neoplasia.
Larsson C; Nordenskjöld M
Cancer Surv; 1990; 9(4):703-23. PubMed ID: 1983211
[TBL] [Abstract][Full Text] [Related]
10. A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10.
Mathew CG; Chin KS; Easton DF; Thorpe K; Carter C; Liou GI; Fong SL; Bridges CD; Haak H; Kruseman AC
Nature; 1987 Aug 6-12; 328(6130):527-8. PubMed ID: 2886917
[TBL] [Abstract][Full Text] [Related]
11. Gene probe analysis in an informative family with multiple endocrine neoplasia syndrome type 2A (MEN 2A). Improvement in carrier risk estimation.
Morrison PJ; Hadden DR; Hughes AE; Kennedy L; Russell CJ; Nevin NC
Q J Med; 1991 Jul; 80(291):597-603. PubMed ID: 1682970
[TBL] [Abstract][Full Text] [Related]
12. Progress toward resolving the possible linkage of multiple endocrine neoplasia type 2A to haptoglobin and group-specific loci: use of restriction fragment length polymorphisms extends exclusion region.
Kidd KK; Kidd JR; Castiglione CM; Pakstis AJ; Sparkes RS
Genet Epidemiol; 1986; 3(3):195-200. PubMed ID: 2873080
[TBL] [Abstract][Full Text] [Related]
13. Changing concepts in the management of hereditary and sporadic medullary thyroid carcinoma.
Grauer A; Raue F; Gagel RF
Endocrinol Metab Clin North Am; 1990 Sep; 19(3):613-35. PubMed ID: 1979773
[TBL] [Abstract][Full Text] [Related]
14. Hereditary medullary thyroid carcinoma.
Vasen HF; Vermey A
Cancer Detect Prev; 1995; 19(2):143-50. PubMed ID: 7750101
[TBL] [Abstract][Full Text] [Related]
15. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.
Moley JF; Brother MB; Fong CT; White PS; Baylin SB; Nelkin B; Wells SA; Brodeur GM
Cancer Res; 1992 Feb; 52(4):770-4. PubMed ID: 1346584
[TBL] [Abstract][Full Text] [Related]
16. One large kindred excludes a locus for multiple endocrine neoplasia type 2A from about 25% of the human autosomal genetic map.
Pakstis AJ; Kidd JR; Castiglione CM; Pletcher BA; Murphy PD; Farrer LA; Genel M; Kidd KK
Henry Ford Hosp Med J; 1987; 35(2-3):164-7. PubMed ID: 2891651
[No Abstract] [Full Text] [Related]
17. [Experience with presymptomatic screening of patients with C cell carcinoma of the thyroid gland].
Frilling A; Röher HD; Ponder BA; Goretzki PE; Schlaghecke R; Reiners C
Chirurg; 1993 Jan; 64(1):28-35. PubMed ID: 8094664
[TBL] [Abstract][Full Text] [Related]
18. Medullary thyroid carcinoma: Australian experience with genetic testing.
Ward JL; Hyland VJ; Andrew DS; Marsh DJ; Robinson BG
Henry Ford Hosp Med J; 1992; 40(3-4):220-3. PubMed ID: 1362409
[TBL] [Abstract][Full Text] [Related]
19. [Medullary cancer of the thyroid and multiple endocrine neoplastic syndromes].
Delisle MJ
Rev Prat; 1992 Apr; 42(7):845-50. PubMed ID: 1351314
[TBL] [Abstract][Full Text] [Related]
20. Current perspectives on the diagnosis and management of patients with multiple endocrine neoplasia type 2 syndromes.
Wells SA; Donis-Keller H
Endocrinol Metab Clin North Am; 1994 Mar; 23(1):215-28. PubMed ID: 7913027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
